U.S., Nov. 29 -- ClinicalTrials.gov registry received information related to the study (NCT07254429) titled 'COMPASS - COpenhagen MenoPAuSe Study' on Sept. 30.
Brief Summary: During menopause, estrogen levels drop while the level of another hormone - LH (luteinizing hormone) substantially increases. This hormonal shift is linked to bone Loss and other complications. Estrogen therapy can help, but some women avoid it due to the increased risk of blood clots and cancer. This project will investigate whether blocking LH could offer a safe alternative to alleviate symptoms and complications of menopause since it is known from previous research that high LH levels contribute to both bone deterioration and metabolic issues. The goal is to explor...